Literature DB >> 28975973

Research on the correlation of diabetes mellitus complicated with osteoporosis with lipid metabolism, adipokines and inflammatory factors and its regression analysis.

Z Chen1, G-H Zhao, Y-K Zhang, G-S Shen, Y-J Xu, N-W Xu.   

Abstract

OBJECTIVE: To investigate the correlation of type 2 diabetes mellitus (DM) complicated with osteoporosis with lipid metabolism, adipokines and inflammatory factors, and to define the risk factors via the multivariate regression analysis. PATIENTS AND METHODS: A total of 80 patients with DM admitted into our hospital from November 2015 to November 2016 were enrolled, including 40 patients complicated with osteoporosis and 40 patients not complicated with osteoporosis. The levels of blood lipid, adipokines and inflammatory factors were compared; the correlations between bone mineral density (BMD) and total cholesterol (TC), adiponectin and tumor necrosis factor-α (TNF-α) were analyzed; and multivariate Logistic regression analysis was performed for osteoporosis, hyperlipidemia, abnormal adipokine levels and body's inflammatory response.
RESULTS: The levels of serum lipid indexes, total cholesterol (TC), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C), in patients without complicating osteoporosis were significantly lower than those in patients complicated with osteoporosis. The level of high-density lipoprotein cholesterol (HDL-C) was significantly higher than that in patients complicated with osteoporosis. The levels of adipokines, adiponectin and visfatin, in patients without complicating osteoporosis were significantly lower than those in patients complicated with osteoporosis. The levels of inflammatory factors, TNF-α, interleukin-6 (IL-6) and C-reactive protein (CRP), in patients without complicating osteoporosis were significantly lower than those in patients complicated with osteoporosis. There were negative correlations between BMD and TC, adiponectin and TNF-α. Abnormal blood lipid, abnormal adipokine levels and elevated inflammatory factor levels were independent risk factors for osteoporosis.
CONCLUSIONS: Enhanced inflammatory response, abnormal blood lipid metabolism and abnormal changes in adipokines may increase the risk of osteoporosis in patients with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28975973

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

1.  Association between lipid biomarkers and osteoporosis: a cross-sectional study.

Authors:  Bo Kan; Qianqian Zhao; Lijuan Wang; Shanshan Xue; Hanqing Cai; Shuman Yang
Journal:  BMC Musculoskelet Disord       Date:  2021-09-06       Impact factor: 2.362

Review 2.  Mapping Knowledge Landscapes and Emerging Trends of the Links Between Bone Metabolism and Diabetes Mellitus: A Bibliometric Analysis From 2000 to 2021.

Authors:  Kunming Cheng; Qiang Guo; Weiguang Yang; Yulin Wang; Zaijie Sun; Haiyang Wu
Journal:  Front Public Health       Date:  2022-06-03

3.  Metrnl deficiency decreases blood HDL cholesterol and increases blood triglyceride.

Authors:  Qi Qi; Wen-Jun Hu; Si-Li Zheng; Sai-Long Zhang; Ying-Ying Le; Zhi-Yong Li; Chao-Yu Miao
Journal:  Acta Pharmacol Sin       Date:  2020-04-07       Impact factor: 6.150

Review 4.  Gut Microbiota in Bone Health and Diabetes.

Authors:  Julie Kristine Knudsen; Peter Leutscher; Suzette Sørensen
Journal:  Curr Osteoporos Rep       Date:  2021-02-01       Impact factor: 5.096

Review 5.  Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis.

Authors:  Eloi Franco-Trepat; María Guillán-Fresco; Ana Alonso-Pérez; Alberto Jorge-Mora; Vera Francisco; Oreste Gualillo; Rodolfo Gómez
Journal:  J Clin Med       Date:  2019-08-07       Impact factor: 4.241

6.  Association of dyslipidaemia with osteoporosis in postmenopausal women.

Authors:  Lingnan Zhang; Qilong Liu; Xianshang Zeng; Wenshan Gao; Yanan Niu; Xiaoyong Ma; Huijun Xie; Xiaozhe Zhou; Weiguang Yu; Guixing Xu
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

7.  Bone metabolic biomarker-based diagnosis of type 2 diabetes osteoporosis by support vector machine.

Authors:  Chuan Wang; Taomin Zhang; Peng Wang; Xuan Liu; Liming Zheng; Lei Miao; Deyu Zhou; Yibo Zhang; Yezi Hu; Han Yin; Qing Jiang; Hui Jin; Jianfei Sun
Journal:  Ann Transl Med       Date:  2021-02

Review 8.  Lipid metabolism within the bone micro-environment is closely associated with bone metabolism in physiological and pathophysiological stages.

Authors:  Bo Wang; Heng Wang; Yuancheng Li; Lei Song
Journal:  Lipids Health Dis       Date:  2022-01-07       Impact factor: 3.876

9.  Association Between Bone Mineral Density, Bone Turnover Markers, and Serum Cholesterol Levels in Type 2 Diabetes.

Authors:  Yinqiu Yang; Guangwang Liu; Yao Zhang; Guiping Xu; Xilu Yi; Jing Liang; Chenhe Zhao; Jun Liang; Chao Ma; Yangli Ye; Mingxiang Yu; Xinhua Qu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-06       Impact factor: 5.555

10.  Catalpol Promotes the Proliferation and Differentiation of Osteoblasts Induced by High Glucose by Inhibiting KDM7A.

Authors:  Jian Cheng; Hai-Yan Xu; Ming-Ming Liu; Jian-Ping Cai; Lei Wang; Zhen Hua; Xiao-Dong Wu; Wei-Ling Huo; Nan-Ning Lv
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-13       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.